Literature DB >> 22119499

Blood platelet biochemistry.

Katleen Broos1, Simon F De Meyer, Hendrik B Feys, Karen Vanhoorelbeke, Hans Deckmyn.   

Abstract

Defects in platelet function or formation increase the risk for bleeding or thrombosis, which indicates the crucial role for platelets in maintaining haemostasis in normal life. Upon vascular injury, platelets instantly adhere to the exposed extracellular matrix which results in platelet activation and aggregation and the formation a haemostatic plug that stops bleeding. To prevent excessive platelet aggregate formation that eventually would occlude the vessels, this self-amplifying process nevertheless requires a tight control. This review intends to give a comprehensive overview of the currently established main mechanisms in platelet function.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22119499     DOI: 10.1016/j.thromres.2011.11.002

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  22 in total

1.  Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.

Authors:  Kanagasabai Vadivel; Sathya-Moorthy Ponnuraj; Yogesh Kumar; Anne K Zaiss; Matthew W Bunce; Rodney M Camire; Ling Wu; Denis Evseenko; Harvey R Herschman; Madhu S Bajaj; S Paul Bajaj
Journal:  J Biol Chem       Date:  2014-09-28       Impact factor: 5.157

2.  The effects of pneumatic tube transport on fresh and stored platelets in additive solution.

Authors:  Per Sandgren; Stella Larsson; Poon Wai-San; Beatrice Aspevall-Diedrich
Journal:  Blood Transfus       Date:  2013-12-03       Impact factor: 3.443

3.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

4.  Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).

Authors:  Bhanu Kanth Manne; Todd M Getz; Craig E Hughes; Osama Alshehri; Carol Dangelmaier; Ulhas P Naik; Steve P Watson; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

5.  Predictors of the success and failure of emergency pelvic artery embolisation for primary postpartum haemorrhage: a 12-year review.

Authors:  Billy Ming Hei Lai; John Sing Fai Shum; Chi Yeung Chu; Sherwin Shing Wai Lo; Kam Ying Lau
Journal:  Singapore Med J       Date:  2016-04-19       Impact factor: 1.858

6.  Molecular underpinnings of integrin binding to collagen-mimetic peptides containing vascular Ehlers-Danlos syndrome-associated substitutions.

Authors:  Cody L Hoop; Allysa P Kemraj; Baifan Wang; Sonal Gahlawat; Madison Godesky; Jie Zhu; Haley R Warren; David A Case; David I Shreiber; Jean Baum
Journal:  J Biol Chem       Date:  2019-08-12       Impact factor: 5.157

Review 7.  Natural Products for Antithrombosis.

Authors:  Cen Chen; Feng-Qing Yang; Qian Zhang; Feng-Qin Wang; Yuan-Jia Hu; Zhi-Ning Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

8.  Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.

Authors:  Véronique Ollivier; Varouna Syvannarath; Angèle Gros; Amena Butt; Stéphane Loyau; Martine Jandrot-Perrus; Benoît Ho-Tin-Noé
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

9.  Platelet aggregation but not activation and degranulation during the acute post-ischemic reperfusion phase in livers with no underlying disease.

Authors:  Rowan F van Golen; Katarzyna M Stevens; Pina Colarusso; Hartmut Jaeschke; Michal Heger
Journal:  J Clin Transl Res       Date:  2015-09-13

10.  Platelet aggregation pathway network-based approach for evaluating compounds efficacy.

Authors:  Jiangyong Gu; Qian Li; Lirong Chen; Youyong Li; Tingjun Hou; Gu Yuan; Xiaojie Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.